American Journal of Molecular Biology

Volume 13, Issue 2 (April 2023)

ISSN Print: 2161-6620   ISSN Online: 2161-6663

Google-based Impact Factor: 0.47  Citations  

Cannabidiol-Mediated Sequestration of Alzheimer’s Amyloid-β Peptides in ADDL Oligomers

HTML  XML Download Download as PDF (Size: 681KB)  PP. 113-126  
DOI: 10.4236/ajmb.2023.132008    196 Downloads   956 Views  

ABSTRACT

Cannabidiol (CBD), one of the most studied phytocannabinoids, is non-psychotropic and can induce protective effects on the central nervous system against acute and chronic brain injury. Interestingly, CBD inhibits processes relating to amyloid beta (Aβ)-induced neurotoxicity in mouse models of Alzheimer’s disease, though the detailed molecular mechanism underlying the CBD neurotoxicity modulation is not fully understood. In this study, using atomic force microscopy, we find that CBD promotes the aggregation of Aβ peptides, enhancing the formation of Aβ oligomers, also known as Aβ-derived diffusible ligands (ADDLs). The CBD-mediated sequestration of Aβ monomers in soluble ADDLs could reduce neurotoxicity. This study highlights a possible role of CBD in modulating the formation of ADDL aggregates and provides insight into potentially neuroprotective properties of CBD in Alzheimer’s disease.

Share and Cite:

Li, Y. , Zhang, F. , Herron, C. , Rosales, I. , Heredia, A. , Buchete, N. and Rodriguez, B. (2023) Cannabidiol-Mediated Sequestration of Alzheimer’s Amyloid-β Peptides in ADDL Oligomers. American Journal of Molecular Biology, 13, 113-126. doi: 10.4236/ajmb.2023.132008.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.